Foghorn Therapeutics Inc. (FHTX) DCF Valuation

Foghorn Therapeutics Inc. (FHTX) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Foghorn Therapeutics Inc. (FHTX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Simplify Foghorn Therapeutics Inc. (FHTX) valuation with this customizable DCF Calculator! Featuring real Foghorn Therapeutics Inc. (FHTX) financials and adjustable forecast inputs, you can test scenarios and uncover Foghorn Therapeutics Inc. (FHTX) fair value in minutes.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .4 1.3 19.2 34.2 57.9 98.0 166.1 281.3 476.6
Revenue Growth, % 0 0 206.74 1357.77 77.63 69.41 69.41 69.41 69.41 69.41
EBITDA -48.8 -66.5 -96.2 -113.8 -104.5 -34.7 -58.8 -99.6 -168.8 -285.9
EBITDA, % 100 -15463.72 -7292.42 -591.93 -305.83 -60 -60 -60 -60 -60
Depreciation 1.8 5.5 7.5 7.9 3.5 40.6 68.8 116.6 197.6 334.7
Depreciation, % 100 1285.58 569.75 41.09 10.1 70.24 70.24 70.24 70.24 70.24
EBIT -50.6 -72.0 -103.7 -121.7 -107.9 -34.7 -58.8 -99.6 -168.8 -285.9
EBIT, % 100 -16749.3 -7862.17 -633.02 -315.93 -60 -60 -60 -60 -60
Total Cash 15.0 185.8 154.3 345.8 234.1 57.9 98.0 166.1 281.3 476.6
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 300.0 .0 .0
Account Receivables, % 100 0 22744.5 0 0
Inventories .0 .0 .0 .0 .0 11.6 19.6 33.2 56.3 95.3
Inventories, % 100 0 0 0 0 20 20 20 20 20
Accounts Payable 3.4 3.7 3.8 5.4 6.3 40.1 67.9 115.1 194.9 330.2
Accounts Payable, % 100 855.81 289.54 28.16 18.33 69.3 69.3 69.3 69.3 69.3
Capital Expenditure -1.0 -16.2 -3.3 -1.2 -1.2 -24.3 -41.1 -69.7 -118.1 -200.0
Capital Expenditure, % 100 -3763.49 -251.18 -6.29 -3.58 -41.98 -41.98 -41.98 -41.98 -41.98
Tax Rate, % -4.49 -4.49 -4.49 -4.49 -4.49 -4.49 -4.49 -4.49 -4.49 -4.49
EBITAT -51.1 -73.0 -105.7 -121.7 -112.7 -34.7 -58.8 -99.6 -168.8 -285.9
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -46.9 -83.5 -401.3 186.6 -109.7 -19.2 -27.4 -46.4 -78.6 -133.1
WACC, % 16.6 16.6 16.6 16.6 16.6 16.6 16.6 16.6 16.6 16.6
PV UFCF
SUM PV UFCF -170.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -136
Terminal Value -930
Present Terminal Value -431
Enterprise Value -601
Net Debt -35
Equity Value -566
Diluted Shares Outstanding, MM 42
Equity Value Per Share -13.49

What You Will Get

  • Pre-Filled Financial Model: Foghorn Therapeutics Inc.'s (FHTX) actual data enables precise DCF valuation.
  • Full Forecast Control: Adjust revenue growth, margins, WACC, and other key drivers specific to FHTX.
  • Instant Calculations: Automatic updates ensure you see results as you make changes to FHTX's financials.
  • Investor-Ready Template: A refined Excel file designed for professional-grade valuation of FHTX.
  • Customizable and Reusable: Tailored for flexibility, allowing repeated use for detailed forecasts of FHTX.

Key Features

  • Customizable Research Parameters: Adjust essential inputs such as drug development timelines, market penetration rates, and R&D expenditures.
  • Instant DCF Valuation: Quickly computes intrinsic value, net present value (NPV), and other financial metrics.
  • High-Precision Accuracy: Leverages Foghorn Therapeutics' actual financial data for credible valuation insights.
  • Streamlined Scenario Testing: Easily evaluate various hypotheses and analyze different outcomes.
  • Efficiency Booster: Avoid the complexities of creating detailed valuation models from the ground up.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review Foghorn Therapeutics Inc.'s pre-filled financial data and projections.
  3. Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model update in real-time as you modify your assumptions.
  5. Step 5: Evaluate the outputs and leverage the results for your investment strategies.

Why Choose This Calculator for Foghorn Therapeutics Inc. (FHTX)?

  • Precision: Utilizes accurate Foghorn Therapeutics financial data for reliable calculations.
  • Customizability: Allows users to adjust and experiment with various inputs seamlessly.
  • Efficiency: Eliminates the need to create a financial model from the ground up.
  • Expert-Level: Crafted with the expertise and detail expected at the CFO level.
  • Intuitive: Designed for ease of use, catering to individuals with varying levels of financial expertise.

Who Should Use This Product?

  • Investors: Evaluate Foghorn Therapeutics Inc.'s (FHTX) valuation before making investment decisions.
  • CFOs and Financial Analysts: Enhance valuation methodologies and assess future projections for FHTX.
  • Biotech Entrepreneurs: Understand the valuation models applied to companies like Foghorn Therapeutics Inc. (FHTX).
  • Consultants: Create comprehensive valuation reports for clients in the biotech sector.
  • Students and Educators: Utilize current market data to explore and teach valuation strategies in biotechnology.

What the Template Contains

  • Pre-Filled Data: Includes Foghorn Therapeutics Inc.'s (FHTX) historical financials and forecasts.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze Foghorn Therapeutics Inc.'s (FHTX) profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.

No products were found matching.